Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping.

Clinica chimica acta; international journal of clinical chemistry - 4 Jul 2010

Maurice Carleta B, Barua Pankaj K, Simses Diane, Smith Penny, Howe John G, Stack Gary

Abstract excerpt

BACKGROUND: A variety of commercial genotyping assays is available to detect variants in the CYP2C9 and VKORC1 genes. The assay results are used in genotype-based warfarin dosing algorithms. We compared the performance of four such assay systems: Verigene, eSensor, Invader, and Luminex. METHODS: Result concordance and no call rates were determined on patient specimens tested on all four instruments. Turnaround...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C9

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Ethanol

Share to Genetic Techniques

Share to Mixed Function Oxygenases

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 20226775
DOI: 10.1016/j.cca.2010.03.005

Genes

TAT
VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of assay systems for warfarin-related CYP2C9 and VKORC1 genotyping.PMID 20226775Read ↗

Comparison of performance of three commercial platforms for warfarin sensitivity genotyping.Semantic proximity Read ↗

Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.Semantic proximity Read ↗

Genotyping for CYP2C9 and VKORC1 alleles by a novel point of care assay with HyBeacon® probes.Semantic proximity Read ↗

A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.Semantic proximity Read ↗

Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.Semantic proximity Read ↗

A multiplex assay for detecting genetic variations in CYP2C9, VKORC1, and GGCX involved in warfarin metabolism.Semantic proximity Read ↗

Evaluation of a CYP2C19 genotype panel on the GenMark eSensor® platform and the comparison to the Autogenomics Infiniti™ and Luminex CYP2C19 panels.Semantic proximity Read ↗

Comparison of Two Point-of-Care CYP2C19 Genotyping Assays for Genotype-Guided Antiplatelet Therapy.Semantic proximity Read ↗

A fully integrated and automated microsystem for rapid pharmacogenetic typing of multiple warfarin-related single-nucleotide polymorphisms.Semantic proximity Read ↗

Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative Project.Semantic proximity Read ↗

New allele-specific real-time PCR system for warfarin dose genotyping equipped with an automatic interpretative function that allows rapid, accurate, and user-friendly reporting in clinical laboratories.Semantic proximity Read ↗

Validation of methodology for efficient genotyping of CYP2D6 and CYP2C19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.